SlideShare a Scribd company logo
BIOSAFETY AND BIOSECURITY
REGULATORY ENVIRONMENT AND
PRACTICES AT SCIENSANO
BELGIUM
Prof. Dr. Steven Van Gucht
Viral Diseases
Sciensano – Brussels
steven.vangucht@Sciensano.be
20th Meeting of the NMFP, 4-5th June 2019, Stockholm
What is Sciensano?
• National research institute for public and animal health
• April 2018 merger: →
• Staff: 700, Sites: 6
Scientific departments
Sciensano
Epidemiology
and public
health
Infectious
diseases in
humans
3 BSL3:
Avian influenza
Rabies virus
TBEV
Mycobacterium
tuberculosis ….
Infectious
diseases in
animals
3 BSL3(+):
Footh and mouth disease
Lumpy skin, capripox
Bluetongue
Schmallenberg
Avian influenza
West Nile virus……
Chemical and
physical health
risks
Expertise and
service
provision
SBB
(Biosafety and
biotechnology
service)
Belgian
Biosafety
server
Biosafety
committee
Regulatory framework
European:
Directive 2009/41/EC of the 6th of May 2009 on the contained use of GMO
Region (competent authority):
Regional decrees (since 1993): Flanders, Brussels, Wallonia
Scope: GMOs and pathogens (human, animal & plants)
Part of Environmental permit
Regulatory framework
Belgian (federal level): coordinates and
harmonizes implementation of EU Directives
↓
Sciensano:
Service of Biosafety and Biotechnology (SBB)
= Centre of expertise
- Belgian Biosafety Council
- Belgian Biosafety Server:
https://www.biosafety.be
Advisory role for regional authorities on
regulations, risk assessments, audits
Authorisation procedure Brussels Region
Biosafety dossier:
- technical (confidential) and public dossier
- Sent to competent authority and advisory body Sciensano (SBB)
Authorisation procedure Brussels Region
Bruxelles Environnement (IBGE BIM):
Central inventory since 1993
Authorization (environmental permit)
Inspections (with support from Sciensano SBB)
User:
Internal audits/ auto control: Biosafety officer
Incident/accident reporting
Yearly Reporting
Sciensano: roles and responsibilities
General Director: approves all new or changed activities
Biosafety Officer: advices personnel and director, contact point
Head of service: specific lab procedures
Sciensano: roles and responsibilities
Biosafety Bureau
• Presided by Biosafety Officer
• Delegate from every building (4), Facility Services, Quality Office
• Prevention Officer (worker’s safety, overlap)
• Delegate Occupational health service (external)
Local Biosafety Council
• Bureau + delegate from every lab/service
• Meets every month
• transfer of information - consultation
• report Incidents/accidents
Sciensano: risk assesment
List of pathogens and risks: https://www.biosafety.be
Risk class pathogen:
• 1 (e.g. bacteriophage)
• 2 (e.g. adenovirus)
• 3 (e.g. rabies virus)
• 4 (e.g.Ebola)
Risk class of activity: PCR versus virus culture, aerosol, volume and
concentration, sharps,…
Risk level pathogen + activity + > Appropriate containment level and
protective measures
Sciensano infrastructure
Requirements: regional authority > based on Belgian biosafety server
Biosafety level labs: 2, 2+, 3, 3+
ASL 2 and 3 (also large animals)
No BSL4 in Belgium
Diagnosis class 4 pathogens in BSL3 lab: e.g. Ebola virus inactivation and RNA
extraction for PCR, no culture
Laboratory equipment
Biosafety cabinets class 2, 3
Individually ventilated cages lab animals
Yearly maintenance, validation, certification by external contractor (cfr ISO17025, 15189)
Personal protective equipment
General budget versus project budget !
Gloves
Lab coats (tight cuffs)
FFP2/3 respiratory masks with fitting tests
Personnel competence and training
New personnel:
General training on biosafety
Lab-specific training by head of lab (no proficiency test)
Recorded in personal training program (cfr ISO17025, ISO15189)
Badge entrance BSL2+ or BSL3 labs: only after vaccination and training
Intranet
Biosafety Manual
Environmental permit
Contact persons
Reporting tool
Occupational health program: worker’s
safety
Legal obligation: medical clearance staff
External (IDEWE)
Risk analysis from head of lab
Preventive and post exposure prophylaxis
1-2/y medical check-up
Update vaccinations and serology if needed:
e.g. monitoring rabies antibodies every 6 months, <3 IU/ml = booster
Site visits
Sample receipt
International legislations: UN, ADR, IATA, Directive 2008/68/EC
Belgian Royal Decree 27/4/2007 (cat B)
Shipper is responsible
• Category A: UN 2814: High risk pathogen (life-threatening):
rigid triple packaging, trained staff, specialized transporter (World Courier)
• Category B: UN3373 regulation: Human samples with biological agent: triple
packaging, labelling, documentation
• Exempt human or animal samples (improbable risk): basic triple packaging
Centralized Dispatching Centre: sample tracking tool in Lab Information System
(LIMS)
Shipment of samples from peripheral lab to
reference lab: weak link
Inter/intra site transport
Decontamination and waste management
SOP: Elimination (PRO/5.1/04)
Bio-hazard containers:
collected by facility services > central storage >
specialized transporter (extern) > incineration (extern)
BSL3:
Autoclave: chemical (tape) and biological (spore)
indicators
Kill tanks for water waste, animal waste and carcasses
Disinfection spray for surfaces or fomites
Incident/emergency response plan
Procedures intranet
Legal obligation to notify
Report to head of lab > prevention officer, medical officer (external), biosafety
officer > report to authorities if necessary
Risk analysis and action plan
Record keeping of accidents/incidents
Accidental spill: spill kit and H2O2 decontamination
Some examples of biosafety incidents
Usually: human errors, lab-acquired infections
www.biosafety.be: survey Laboratory-Acquired Infections Belgium 2007-2012
Rabies: needle stick and eye exposure
Shigella contamination Sangria
Mycobacterium tuberculosis in researcher:
• Mantoux test / 6 months > IGRA test
• Thorax scan: granuloma’s > biopsy > isolation lab strain > treatment
Biosecurity
No regulation
Restriction for polioviruses only (GAPIII implementation)
Restricted access building and BSL3: yes
No risk assessment or audits
Inventory pathogens: no centralized control or procedure
Personnel background screening: no
My opinion:
limited risk from outsiders
potential risk: malignant insiders (e.g. stock of botulin toxins)
gain of function studies
Personnal experience
Risk perception: individual and lab culture
Risk of short term contracts and staff
turnover
My mantra:
No needles, rush or fear
Use disposables
Understand what you do
Thanks for your attention !

More Related Content

PPT
Safety considerations and guidelines veterinary microbiology laboratory
PDF
WHO Laboratory Biosafety Manual Revision Update
PPTX
Safety and biosecurity (lab1)
PPT
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
PPTX
Lecture 1 introduction of biosafety & biosecurity
PPTX
Biosafety &amp; biosecurity overview naypyitaw
PPTX
Biosafety
PPTX
Biosafety levels with video guideline
Safety considerations and guidelines veterinary microbiology laboratory
WHO Laboratory Biosafety Manual Revision Update
Safety and biosecurity (lab1)
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
Lecture 1 introduction of biosafety & biosecurity
Biosafety &amp; biosecurity overview naypyitaw
Biosafety
Biosafety levels with video guideline

What's hot (20)

PPT
Lab biosafety and biosecurity
PDF
Recognizing the Biosafety level
PPTX
Laboratory Biosecurity by Dr.Abdoalati Mohammed Alswehli
PPTX
Laboratory biosafety levels and transfer of biological samples
PPT
Biosafety level and biosafety cabinets
PPT
Basic Biorisk Management for BAI
PPTX
8. principles of biosafety, biocontainment & program management (nbb160)
PPTX
Scope, roles and responsibilities of microbiologist in
PPTX
Quality Assurance in Clinical Microbiology
PPT
Biosafety Levels, Biological Safety Cabinets and Biosafety Laboratory Constru...
PPTX
Microbiology lab QC
PPT
Biosafety
PPTX
Peeeeeeeeeeef
PPTX
Introduction to Basic Pharmaceutical Microbiology
PPTX
Biosafety in Microbiology laboratory
PPTX
Biosafety Basics Training
PPTX
Automated methods in the microbiology lab
PPTX
KPIs in Microbiology
PPTX
Introduction of Biosafety
PPTX
Bioburden Testing
Lab biosafety and biosecurity
Recognizing the Biosafety level
Laboratory Biosecurity by Dr.Abdoalati Mohammed Alswehli
Laboratory biosafety levels and transfer of biological samples
Biosafety level and biosafety cabinets
Basic Biorisk Management for BAI
8. principles of biosafety, biocontainment & program management (nbb160)
Scope, roles and responsibilities of microbiologist in
Quality Assurance in Clinical Microbiology
Biosafety Levels, Biological Safety Cabinets and Biosafety Laboratory Constru...
Microbiology lab QC
Biosafety
Peeeeeeeeeeef
Introduction to Basic Pharmaceutical Microbiology
Biosafety in Microbiology laboratory
Biosafety Basics Training
Automated methods in the microbiology lab
KPIs in Microbiology
Introduction of Biosafety
Bioburden Testing
Ad

Similar to BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO BELGIUM (20)

PPT
Biosafety
PPT
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...
PPT
Basic Principles of Biosafety
PPSX
Biosafety
PDF
abstract....BIOBIOLE2.pdfabstract.....BIOBIOLECT2
PPT
Biosafety
PPTX
Biosafety lecture and bio hazards 1.pptx
PPT
Main steps in bacteriological diagnosis
PPTX
Biorisk Management 2020.pptx
PPT
Microbiology laboratories: some relevant definitions and elements of biosafety
PPT
PDF
PPTX
Biosafety/Bloodborne Pathogens Training for Laboratory Workers
PPTX
Biosafety & Bloodborne Pathogens Training for Laboratory Workers
PPTX
Final-MoH_Ebola Laboratory Training_18_10_2022.pptx
PPT
Implementing A Network Of Virology And Entomology Laboratories For A OH Appro...
PDF
Conducting Vivarium Risk Assessments in the Research Environment
PPT
Biological Laboratory Safety Biocontainment labs
PPT
Safety measures and infection control
PPTX
biosafety presentation
Biosafety
NADIR: the European “Network for Animal Diseases Infectiology Research” faci...
Basic Principles of Biosafety
Biosafety
abstract....BIOBIOLE2.pdfabstract.....BIOBIOLECT2
Biosafety
Biosafety lecture and bio hazards 1.pptx
Main steps in bacteriological diagnosis
Biorisk Management 2020.pptx
Microbiology laboratories: some relevant definitions and elements of biosafety
Biosafety/Bloodborne Pathogens Training for Laboratory Workers
Biosafety & Bloodborne Pathogens Training for Laboratory Workers
Final-MoH_Ebola Laboratory Training_18_10_2022.pptx
Implementing A Network Of Virology And Entomology Laboratories For A OH Appro...
Conducting Vivarium Risk Assessments in the Research Environment
Biological Laboratory Safety Biocontainment labs
Safety measures and infection control
biosafety presentation
Ad

More from European Center for Disease Prevention and Control (ECDC) (20)

PDF
EULabCap methods and indicators: technical updates and survey calendar
PDF
Biosafety checks and controls in national public health reference laboratory ...
PDF
Survey on automated laboratory information reporting practices in the EU/EEA,...
PDF
ECDC projects and collaborations on digital surveillance
PDF
Demonstration of ECDC web interface platform for molecular and genomic epidem...
PDF
Options for RSV surveillance in Europe
PDF
WHO global RSV surveillance schema for future planning. Moving from RSV detec...
PDF
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...
PDF
ECDC and WHO collaborative activities to improve laboratory preparedness
PDF
European Commission support actions for laboratory preparedness
PDF
ECDC public health microbiology programme … partnerships in action!
PDF
How do advances in technology help us respond to Emerging Infections?
PDF
Use of and impact of EULabCap monitoring in Austria
PDF
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
PDF
ECDC typing WGS roadmap revision plan, 2018
PDF
ECDC webportal microbiology information
PDF
EUCAST and National Antimicrobial Susceptibility Testing Committees
PDF
ECDC Strategy for laboratory EQA 2017-2020
PDF
Who europe update on polio eradication
PDF
Feedback from the national focal points for surveillance
EULabCap methods and indicators: technical updates and survey calendar
Biosafety checks and controls in national public health reference laboratory ...
Survey on automated laboratory information reporting practices in the EU/EEA,...
ECDC projects and collaborations on digital surveillance
Demonstration of ECDC web interface platform for molecular and genomic epidem...
Options for RSV surveillance in Europe
WHO global RSV surveillance schema for future planning. Moving from RSV detec...
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...
ECDC and WHO collaborative activities to improve laboratory preparedness
European Commission support actions for laboratory preparedness
ECDC public health microbiology programme … partnerships in action!
How do advances in technology help us respond to Emerging Infections?
Use of and impact of EULabCap monitoring in Austria
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
ECDC typing WGS roadmap revision plan, 2018
ECDC webportal microbiology information
EUCAST and National Antimicrobial Susceptibility Testing Committees
ECDC Strategy for laboratory EQA 2017-2020
Who europe update on polio eradication
Feedback from the national focal points for surveillance

Recently uploaded (20)

PDF
Transcultural that can help you someday.
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PPTX
Morphology of Bacterial Cell for bsc sud
PDF
TISSUE LECTURE (anatomy and physiology )
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Reading between the Rings: Imaging in Brain Infections
PPT
Infections Member of Royal College of Physicians.ppt
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Post Op complications in general surgery
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
2 neonat neotnatology dr hussein neonatologist
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
Anatomy and physiology of the digestive system
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
Acute Coronary Syndrome for Cardiology Conference
Transcultural that can help you someday.
antibiotics rational use of antibiotics.pptx
CHEM421 - Biochemistry (Chapter 1 - Introduction)
HIV lecture final - student.pptfghjjkkejjhhge
Morphology of Bacterial Cell for bsc sud
TISSUE LECTURE (anatomy and physiology )
1. Basic chemist of Biomolecule (1).pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Reading between the Rings: Imaging in Brain Infections
Infections Member of Royal College of Physicians.ppt
preoerative assessment in anesthesia and critical care medicine
Post Op complications in general surgery
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
surgery guide for USMLE step 2-part 1.pptx
2 neonat neotnatology dr hussein neonatologist
شيت_عطا_0000000000000000000000000000.pdf
Anatomy and physiology of the digestive system
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
y4d nutrition and diet in pregnancy and postpartum
Acute Coronary Syndrome for Cardiology Conference

BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO BELGIUM

  • 1. BIOSAFETY AND BIOSECURITY REGULATORY ENVIRONMENT AND PRACTICES AT SCIENSANO BELGIUM Prof. Dr. Steven Van Gucht Viral Diseases Sciensano – Brussels steven.vangucht@Sciensano.be 20th Meeting of the NMFP, 4-5th June 2019, Stockholm
  • 2. What is Sciensano? • National research institute for public and animal health • April 2018 merger: → • Staff: 700, Sites: 6
  • 3. Scientific departments Sciensano Epidemiology and public health Infectious diseases in humans 3 BSL3: Avian influenza Rabies virus TBEV Mycobacterium tuberculosis …. Infectious diseases in animals 3 BSL3(+): Footh and mouth disease Lumpy skin, capripox Bluetongue Schmallenberg Avian influenza West Nile virus…… Chemical and physical health risks Expertise and service provision SBB (Biosafety and biotechnology service) Belgian Biosafety server Biosafety committee
  • 4. Regulatory framework European: Directive 2009/41/EC of the 6th of May 2009 on the contained use of GMO Region (competent authority): Regional decrees (since 1993): Flanders, Brussels, Wallonia Scope: GMOs and pathogens (human, animal & plants) Part of Environmental permit
  • 5. Regulatory framework Belgian (federal level): coordinates and harmonizes implementation of EU Directives ↓ Sciensano: Service of Biosafety and Biotechnology (SBB) = Centre of expertise - Belgian Biosafety Council - Belgian Biosafety Server: https://www.biosafety.be Advisory role for regional authorities on regulations, risk assessments, audits
  • 6. Authorisation procedure Brussels Region Biosafety dossier: - technical (confidential) and public dossier - Sent to competent authority and advisory body Sciensano (SBB)
  • 7. Authorisation procedure Brussels Region Bruxelles Environnement (IBGE BIM): Central inventory since 1993 Authorization (environmental permit) Inspections (with support from Sciensano SBB) User: Internal audits/ auto control: Biosafety officer Incident/accident reporting Yearly Reporting
  • 8. Sciensano: roles and responsibilities General Director: approves all new or changed activities Biosafety Officer: advices personnel and director, contact point Head of service: specific lab procedures
  • 9. Sciensano: roles and responsibilities Biosafety Bureau • Presided by Biosafety Officer • Delegate from every building (4), Facility Services, Quality Office • Prevention Officer (worker’s safety, overlap) • Delegate Occupational health service (external) Local Biosafety Council • Bureau + delegate from every lab/service • Meets every month • transfer of information - consultation • report Incidents/accidents
  • 10. Sciensano: risk assesment List of pathogens and risks: https://www.biosafety.be Risk class pathogen: • 1 (e.g. bacteriophage) • 2 (e.g. adenovirus) • 3 (e.g. rabies virus) • 4 (e.g.Ebola) Risk class of activity: PCR versus virus culture, aerosol, volume and concentration, sharps,… Risk level pathogen + activity + > Appropriate containment level and protective measures
  • 11. Sciensano infrastructure Requirements: regional authority > based on Belgian biosafety server Biosafety level labs: 2, 2+, 3, 3+ ASL 2 and 3 (also large animals) No BSL4 in Belgium Diagnosis class 4 pathogens in BSL3 lab: e.g. Ebola virus inactivation and RNA extraction for PCR, no culture
  • 12. Laboratory equipment Biosafety cabinets class 2, 3 Individually ventilated cages lab animals Yearly maintenance, validation, certification by external contractor (cfr ISO17025, 15189)
  • 13. Personal protective equipment General budget versus project budget ! Gloves Lab coats (tight cuffs) FFP2/3 respiratory masks with fitting tests
  • 14. Personnel competence and training New personnel: General training on biosafety Lab-specific training by head of lab (no proficiency test) Recorded in personal training program (cfr ISO17025, ISO15189) Badge entrance BSL2+ or BSL3 labs: only after vaccination and training Intranet Biosafety Manual Environmental permit Contact persons Reporting tool
  • 15. Occupational health program: worker’s safety Legal obligation: medical clearance staff External (IDEWE) Risk analysis from head of lab Preventive and post exposure prophylaxis 1-2/y medical check-up Update vaccinations and serology if needed: e.g. monitoring rabies antibodies every 6 months, <3 IU/ml = booster Site visits
  • 16. Sample receipt International legislations: UN, ADR, IATA, Directive 2008/68/EC Belgian Royal Decree 27/4/2007 (cat B) Shipper is responsible • Category A: UN 2814: High risk pathogen (life-threatening): rigid triple packaging, trained staff, specialized transporter (World Courier) • Category B: UN3373 regulation: Human samples with biological agent: triple packaging, labelling, documentation • Exempt human or animal samples (improbable risk): basic triple packaging Centralized Dispatching Centre: sample tracking tool in Lab Information System (LIMS)
  • 17. Shipment of samples from peripheral lab to reference lab: weak link
  • 19. Decontamination and waste management SOP: Elimination (PRO/5.1/04) Bio-hazard containers: collected by facility services > central storage > specialized transporter (extern) > incineration (extern) BSL3: Autoclave: chemical (tape) and biological (spore) indicators Kill tanks for water waste, animal waste and carcasses Disinfection spray for surfaces or fomites
  • 20. Incident/emergency response plan Procedures intranet Legal obligation to notify Report to head of lab > prevention officer, medical officer (external), biosafety officer > report to authorities if necessary Risk analysis and action plan Record keeping of accidents/incidents Accidental spill: spill kit and H2O2 decontamination
  • 21. Some examples of biosafety incidents Usually: human errors, lab-acquired infections www.biosafety.be: survey Laboratory-Acquired Infections Belgium 2007-2012 Rabies: needle stick and eye exposure Shigella contamination Sangria Mycobacterium tuberculosis in researcher: • Mantoux test / 6 months > IGRA test • Thorax scan: granuloma’s > biopsy > isolation lab strain > treatment
  • 22. Biosecurity No regulation Restriction for polioviruses only (GAPIII implementation) Restricted access building and BSL3: yes No risk assessment or audits Inventory pathogens: no centralized control or procedure Personnel background screening: no My opinion: limited risk from outsiders potential risk: malignant insiders (e.g. stock of botulin toxins) gain of function studies
  • 23. Personnal experience Risk perception: individual and lab culture Risk of short term contracts and staff turnover My mantra: No needles, rush or fear Use disposables Understand what you do
  • 24. Thanks for your attention !